GenVisc 850 × Medicare

GenVisc 850 Insurance Coverage with Medicare

Everything you need to know about getting GenVisc 850 viscosupplementation injections covered under Medicare, including requirements, costs, and approval steps.

Covered with Requirements

Medicare covers GenVisc 850 when medical necessity and plan requirements are met.

Coverage Details

Coverage Status

Covered

Prior Authorization

Not typically required

Estimated Cost

$75-$200 with insurance

With insurance

Injection Schedule

5 weekly injections

Can repeat Every 6 months as needed

Coverage Notes: Covered under Medicare Part B as a physician-administered injection series. Patient pays 20% coinsurance after meeting Part B deductible.

Prior Authorization for HA Injections

Prior authorization is generally not required

Medicare typically does not require prior authorization for GenVisc 850. However, your provider should verify eligibility and ensure documentation supports medical necessity.

Coverage Requirements

Medicare typically requires the following for GenVisc 850 coverage:

Diagnosis of knee osteoarthritis (ICD-10 M17.x)
X-ray evidence of joint degeneration within past 12 months
Documentation of failed conservative treatment (3+ months)
Treatment by a Medicare-enrolled provider

Expected Costs

Scenario	Estimated Cost
With Medicare coverage	$75-$200 with insurance
Self-pay (without insurance)	$500-$800 per course (5 injections)
Number of injections	5 weekly injections
Repeat frequency	Every 6 months as needed

Costs are estimates and may vary based on your specific plan, location, and provider. Contact Medicare to verify your exact out-of-pocket costs.

How to Get Approved

Follow these steps to ensure your GenVisc 850 treatment is approved by Medicare:

1 Request the specific denial reason in writing from your MAC
2 Gather knee X-rays and conservative treatment records
3 Have your physician submit a letter of medical necessity
4 Include peer-reviewed studies supporting Hyalgan efficacy
5 File your appeal within 120 days of the denial notice

Other HA Brands & Medicare

Compare how Medicare covers other viscosupplementation brands:

Brand	Schedule	Source	Cost w/ Insurance	Details
Synvisc-One	Single injection	Avian	$100-$300 with Medicare/insurance	View
Monovisc	Single injection	Avian	$100-$350 with insurance	View
Durolane	Single injection	Non-Avian	$150-$400 with insurance	View
Gel-One	Single injection	Avian	$100-$300 with insurance	View
Hymovis	2 weekly injections	Non-Avian	$100-$300 with insurance	View
Euflexxa	3 weekly injections	Non-Avian	$75-$250 with insurance	View
Gelsyn-3	3 weekly injections	Non-Avian	$75-$200 with insurance	View
SynoJoynt	3 weekly injections	Non-Avian	$75-$200 with insurance	View

Compare Insurance Plans for GenVisc 850

See how other insurance plans cover GenVisc 850:

What Your Doctor Needs to Submit

To get GenVisc 850 approved by Medicare, your doctor's office will need to prepare the following documentation:

Knee Osteoarthritis Diagnosis

Confirmed diagnosis of knee OA using ICD-10 code M17 (or appropriate subcode). The documentation should include clinical findings from physical examination.

X-Ray Evidence

Radiographic imaging showing joint space narrowing, osteophytes, or other degenerative changes consistent with knee osteoarthritis. Images should be recent (within 6-12 months).

Failed Conservative Treatment

Records showing the patient tried and failed conservative treatments for at least 3-6 months. This includes physical therapy, exercise, weight management, OTC pain medications, and/or prescription anti-inflammatories.

Letter of Medical Necessity

A written statement from the treating physician explaining why GenVisc 850 is medically necessary for this patient, including why conservative treatments were insufficient.

Prior Authorization Form

While prior authorization may not be required, having documentation ready helps avoid delays. Include the appropriate J-code for GenVisc 850 and supporting clinical information.

Tip: Ask your doctor's office to confirm they have all required documentation before submitting to Medicare. Incomplete submissions are the most common reason for delays and initial denials.

Frequently Asked Questions

Does Medicare cover GenVisc 850?

Yes, Medicare typically covers GenVisc 850 viscosupplementation injections for knee osteoarthritis when medical necessity is established. Coverage requires meeting specific requirements such as prior authorization and documentation of failed conservative treatments. The estimated cost with insurance is $75-$200 with insurance.

How much does GenVisc 850 cost with Medicare?

With Medicare coverage, the estimated out-of-pocket cost for GenVisc 850 is $75-$200 with insurance. This includes the 5 weekly injections injection schedule. Without insurance, the cost ranges from $500-$800 per course (5 injections). Your actual cost depends on your specific plan's deductible, copay, and coinsurance structure.

Do I need prior authorization for GenVisc 850 with Medicare?

Medicare generally does not require prior authorization for GenVisc 850. However, your provider should verify your eligibility and ensure documentation supports medical necessity. Requirements can vary by specific plan, so it is always wise to confirm with your insurance before scheduling.

What is the injection schedule for GenVisc 850?

GenVisc 850 uses a 5 weekly injections schedule. It is manufactured by OrthoPharma and uses a non-avian (biofermented) hyaluronic acid source with Medium (850 kDa average) molecular weight. Treatment can be repeated Every 6 months as needed.

What if Medicare denies coverage for GenVisc 850?

If denied, you have the right to appeal. Ask for the denial reason in writing, then work with your doctor to submit an appeal including X-ray evidence of osteoarthritis, documentation of at least 3-6 months of failed conservative treatments (physical therapy, OTC pain relievers, exercise), and a letter of medical necessity from your doctor. Many initially denied claims are approved on appeal. You can also ask about alternative covered brands.